Add Yahoo as a preferred source to see more of our stories on Google. Liraglutide slashes chronic migraine days in new study, showing promise as a treatment beyond weight loss. (CREDIT: Shutterstock) ...

Mona Mashayekhi MD, PhD, Assistant Professor of Medicine in the Division of Diabetes, Endocrinology and Metabolism "Our research suggests that liraglutide, and presumably other GLP-1R agonists, are ...

Biocon Limited's wholly owned subsidiary Biocon Pharma Limited has received approval from the U.S. Food and Drug Administration (USFDA) for its Abbreviated New Drug Application ...

Please provide your email address to receive an email when new articles are posted on . In patients with type 2 diabetes but usually not heart disease, liraglutide had better CV outcomes vs. some ...

According to the Company, the generic product will launch immediately. The Food and Drug Administration (FDA) has approved Liraglutide Injection, the first generic version of Victoza ®. Liraglutide is ...

Due to its profound impact on public health and well-being, obesity has become a critical research topic. The rising global prevalence of obesity has placed a tremendous burden on people, communities, ...

Liraglutide (Victoza), a type 2 diabetes drug, may help prevent peripheral artery disease (PAD) progression, the small, open-label STARDUST trial suggested. Over 6 months, adults with type 2 diabetes ...

DUBLIN--(BUSINESS WIRE)--The "Liraglutide and Semaglutide Market by Type, by Route of Administration, by Application, by Distribution Channel, and by Region" report has been added to ...

Liraglutide slashes chronic migraine days in new study, showing promise as a treatment beyond weight loss. (CREDIT: Shutterstock) In a Naples clinic, an unexpected link between a diabetes medication ...